CSF1R and Hodgkins lymphoma: For example, Hodgkin’s lymphoma cells can aberrantly express CSF-1R and are sensitive to CSF-1R inhibitor therapy; thus, the CSF-1R pathway could be a potential target for the treatment of Hodgkin’s lymphoma.